Roles of insulin signalling and p38 MAPK in the activation by lithium of glucose transport in insulin-resistant rat skeletal muscle

Archives of Physiology and Biochemistry

Volumn 114, Issue 5, 2008, Pages 331-339

  Macko, Antoni R ^a   Beneze, Alan N ^a   Teachey, Mary K ^a   Henriksen, Erik J ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

A304000; Akt; Glycogen synthase kinase 3; Obese Zucker rat

Indexed keywords

GLUCOSE; GLYCOGEN; INSULIN; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL; ARTICLE; BIOSYNTHESIS; CATTLE; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; INSULIN RESISTANCE; MALE; METABOLISM; PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ZUCKER RAT;

ANIMALS; CATTLE; ENZYME ACTIVATION; FEMALE; GLUCOSE; GLYCOGEN; INSULIN; INSULIN RESISTANCE; LITHIUM; MALE; MUSCLE, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, ZUCKER; SIGNAL TRANSDUCTION;

RATTUS;

EID: 57649139250     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450802536067     Document Type: Article

References (38)

1. Anai M, Funaki M, Ogihara T, Terasaki J, Inukai K, Katagiri H, Fukushima Y, Yazaki, Y, Kikuchi M, Oka Y, et al. 1998. Altered expression levels and impaired steps in pathways to phosphatidylinositol-3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes 47:13-23.
2. Antonescu CN, Huang C, Niu W, Liu Z, Eyers PA, Heidenreich KA, Bilan PJ, Klip A. 2005. Reduction of insulin-stimulated glucose uptake in L6 myotubes by the protein kinase inhibitor SB203580 in independent of p38MAPK activity. Endocrinology 146:3773-81.
3. Crettaz M, Prentki M, Zaninetti D, Jeanrenaud B. 1980. Insulin resistance in soleus muscle from obese Zucker rats:involvement of several defective sites. Biochem J 186:525-34.
4. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-9.
5. Eldar-Finkelman H, Ilouz R. 2003. Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and type 2 diabetes treatment. Expert Opin Invest Drugs 12:1511-19.
6. Etgen GJ, Wilson CM, Jensen J, Cushman SW, Ivy JL. 1996. Glucose transport and cell surface GLUT-4 protein in skeletal muscle of the obese Zucker rat. Am J Physiol Endocrinol Metab 271:E294-E301.
7. Fürnsinn C, Noe C, Herdlicka R, Roden M, Nowotny P, Leighton B, Waldhäusl. 1997. More marked stimulation by lithium than insulin of the glycogenic pathway in rat skeletal muscle. Am J Physiol Endocrinol Metab 273:E514-E520.
8. Furtado LM, Poon V, Klip A. 2003. GLUT4 activation: some thoughts on possible mechanisms. Acta Physiol Scand 178:287-96.
9. Hajduch E, Alessi DR, Hemmings BA, Hundal HS. 1998. Constitutive activation of protein kinase Ba by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 47:1006-13.
10. Hansen PA, Gulve EA, Holloszy JO. 1994. Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol 76:1862-7.
11. Harrell NB, Teachey MK, Gifford NJ, Henriksen EJ. 2007. Essential role of p38 MAPK for activation of skeletal muscle glucose transport by lithium. Arch Physiol Biochem 113:221-7.
12. Henriksen EJ, Bourey RE, Rodnick KJ, Koranyi L, Permutt MA, Holloszy JO. 1990. Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am J Physiol Endocrinol Metab 259:E593-E598.
13. Henriksen EJ, Dokken BB. 2006. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Current Drug Targets 7:1435-42.
14. Henriksen EJ, Jacob S. 1995. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 44:267-72.
15. Henriksen EJ, Kinnick TR, Teachey MK, O'Keefe MP, Ring D, Johnson KW, Harrison SD. 2003. Modulation of muscle insulin resistance by selective glycogen synthase kinase-3 inhibition in Zucker Diabetic Fatty rats. Am J Physiol Endocrinol Metab 284:E892-E900.
16. Henriksen EJ, Teachey MK. 2007. Short-term in vitro inhibition of glycogen synthase kinase-3 potentiates insulin signalling in skeletal muscle of Zucker Diabetic Fatty rats. Metabolism 56:931-938.
17. Henriksen EJ, Tischler ME, Johnson DG. 1986. Increased response to insulin of glucose metabolism in the 6-day unloaded rat soleus muscle. J Biol Chem 261:10707-12.
18. Kim JS, Saengsirisuwan V, Sloniger JA, Teachey MK, Henriksen EJ. 2006. Stimulation of muscle glucose transport by an oxidant stress: roles of insulin signalling and p38 MAP kinase. Free Rad Biol Med 41:818-24.
19. King PA, Horton ED, Hirshman MF, Horton ES. 1993. Insulin resistance in obese Zucker rat (fa/fa) is associated with a failure of glucose transporter translocation. J Clin Invest 90:1568-75.
20. Kohn AD, Summers SA, Birnbaum MJ, Roth RA. 1996. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulated glucose uptake and glucose transporter 4 translocation. J Biol Chem 271:31372-8.
21. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, Klip A. 2001. The anti-hyperglycemic drug α-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation. Diabetes 50:1464-71.
22. MacAulay K, Hajduch E, Blair A, Coghlan MP, Smith SA, Hundal HS. 2003. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase. Eur J Biochem 270:3829-38.
23. Mathe D. 1995. Dyslipidemia and diabetes: animal models. Diab Metabol 21:106-11.
24. O'Keefe MP, Perez FR, Kinnick TR, Tischler ME, Henriksen EJ. 2004. Development of whole-body and skeletal muscle insulin resistance after one day of hind limb suspension. Metabolism 53:1215-22.
25. Parker PJ, Caudwell FB, Cohen P. 1983. Glycogen synthase from rabbit skeletal muscle: effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo. Eur J Biochem 130:227-34.
26. Roach PJ. 1990. Control of glycogen synthase by hierarchal protein phosphorylation. FASEB J 4:2961-8.
27. Saengsirisuwan V, Perez FR, Sloniger JA, Maier T, Henriksen EJ. 2004. Interactions of exercise training and R-(+)-alpha-lipoic acid on insulin signalling in skeletal muscle of obese Zucker rats. Am J Physiol Endocrinol Metab 287:E529-E536.
28. Shepherd PR, Kahn BB. 1999. Glucose transporters and insulin action. N Eng J Med 341:248-57.
29. Somwar R, Koterski S, Sweeney G, Sciotti R, Djuric S, Berg C, Trevillyan J, Scherer PE, Rondinone CM, Klip A. 2002. A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation. J Biol Chem 277:50386-95.
30. Somwar R, Perreault M, Kapur S, Tahu C, Sweeney G, Ramlal T, Kim DY, Keen J, Cote CH, Klip A, et al. 2000. Activation of p38 mitogen-activated protein kinase α and β by insulin and contraction in rat skeletal muscle. Potential role in the stimulation of glucose transport. Diabetes 49:1794-800.
31. Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A. 1999. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274:10071-8.
32. Tabata I, Schluter J, Gulve EA, Holloszy JO. 1994. Lithium increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes 43:903-7.
33. Ueki K, Yamamoto-Honda R, Kaburagi Y, Yamauchi T, Tobe K, Burgering BMT, Coffer PJ, Komuro I, Akanuma Y, Yazaki Y, et al. 1998. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 273:5315-22.
34. Van de Velde C, Gordon M. 1969. Manic-depressive illness, diabetes mellitus, and lithium carbonate. Arch Gen Psych 21:478-85.
35. Vornik LA, Brown ES. 2006. Management of comorbid bipolar disorder and substance abuse. J Clin Psych 67(Suppl 7):24-30.
36. Wagman AS, Johnson KW, Bussiere DE. 2004. Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes. Curr Pharmaceut Design 10:1105-37.
37. Zhang W, DePaoli-Roach AA, Roach PJ. 1993. Mechanisms of multisite phosphorylation and inactivation of rabbit muscle glycogen synthase. Arch Biochem Biophys 304:219-25.
38. Zierath JR, Krook A, Wallberg-Henriksson H. 2000. Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43:821-35.